Rising Advancements in Medical Technology Drives the U.S. Maternal Health Devices Market Growth

Maternal health devices refer to a specialized category of medical tools and equipment designed for monitoring, diagnosing, and enhancing the well-being of pregnant women and their unborn babies. These devices encompass various products, including fetal monitoring devices, obstetric tools, birthing beds, delivery chairs, and disposable supplies. The primary objective of maternal health devices is to ensure comprehensive care throughout pregnancy, childbirth, and postpartum, contributing to the safety and health of both the mother and the newborn.

Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/us-maternal-health-devices-market

Data Bridge Market Research analyzes that the U.S. Maternal Health Devices Market is expected to reach USD 3,775.52 million by 2031 from USD 2,618.06 million in 2023 growing with a  CAGR of 4.9% in the forecast period of 2024 to 2031. The obstetric devices segment is projected to propel the market growth due to the rising awareness among the expectant mothers.

Key Findings of the Study

Increasing Complications in Pregnancy Related Issues

There is an increasing need for contemporary equipment that can effectively monitor and manage pregnancy or prenatal difficulties as a growing number of pregnancies become complicated by conditions ranging from chronic illness to prenatal concerns. Increased surveillance and aggressive intervention measures are required due to the rising incidence of complications such as gestational diabetes, preeclampsia, and maternal hypertension. Early detection and management of these issues increasingly depend on maternal health equipment that monitors vital signs, blood sugar levels, and fetal health. Substantial innovation and development are driven by the need for more advanced, accurate, and user-friendly technology to meet the various needs of healthcare professionals and pregnant women. The market for maternal health devices is experiencing innovation driven by increased demand for devices that can manage problems and monitor high-risk pregnancies. Innovative technologies, including wearable sensors, remote monitoring systems, and AI-driven analytics, are being developed to address these issues and eventually enhance maternal healthcare outcomes. Thus, the increasing complications in pregnancy require more advanced devices, boosting the market growth.

Report Scope and Market Segmentation

Segment Analysis

The U.S. maternal health devices market is categorized into six notable segments based on by product type, modality, stage, type, end user, and distribution channel.

• On the basis of product type, the market is segmented into fetal monitoring devices, obstetrics devices, birthing beds, delivery chairs, and disposables supplies and consumables

In 2024, the obstetric devices segment of the product type segment is expected to dominate the market

In 2024, the obstetric devices segment is expected to dominate the market due to the rising of the awareness of health care with a market share of 31.49%.

• On the basis of modality, the market is segmented into handheld, portable, standalone, wearables, and others

In 2024, the handheld segment of the modality segment is expected to dominate the market

In 2024, the handheld segment is expected to dominate the market due to rise in the research and development activities of healthcare industry with a market share of 34.16%.

• On the basis of stage, the market is segmented into prenatal stage and birthing stage. In 2024, the prenatal stage segment is expected to dominate the market with a market share of 59.75%
• On the basis of type, the market is segmented into point of care devices and traditional. In 2024, the point of care devices segment is expected to dominate the market with a market share of 62.96%
• On the basis of end user, the market is segmented into hospital, maternity centers, nursing facilities, specialty clinics, homecare settings, and others. In 2024, the hospital segment is expected to dominate the market with a market share of 87.40%
• On the basis of distribution channel, the market is segmented into direct tender, retail sales, online sales and others. In 2024, the direct tender segment is expected to dominate the market with a market share of 40.32%

Major Players

Data Bridge Market Research analyses Medtronic (Ireland), Stryker (U.S.), GE HealthCare (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Hill-Rom Holdings Inc. (A Subsidiary of Baxter) (U.S.) as the major companies in the U.S. maternal health devices market.

Market Development

• In December 2023, Medotronic announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally. Through this exclusive global partnership, Medtronic and Cosmo Pharmaceuticals remain committed to revolutionizing endoscopy by harnessing the power of AI to improve patient outcomes. This strategic alliance reinforces Medtronic's position in AI-integrated healthcare solutions and represents a significant leap in incorporating AI into endoscopic care
• In December 2023, Stryker declared that it has completed a legally binding offer to Menix to purchase the joint replacement business SERF SAS, which is headquartered in France. Healthcare specialists worldwide acknowledge ERF SAS for its technological advancements, which include creating the first Dual Mobility Cup. With this acquisition, Stryker could provide joint replacements to a larger patient base and enhance its current position in France and throughout Europe in addition to its global joint replacement portfolio
• In December 2023, Cook MedSurg division received the 2023 Loyal Partner Supplier Award from Capstone Health Alliance in recognition of their exceptional work. Cook is thrilled to get this recognition in addition to a new contract for urological supplies
• In July 2023, CANON  MEDICAL SYSTEMS CORPORATION introduced the two most recent high-end compact ultrasound systems, the Aplio flex, and Aplio go. The company is aware of the significance of providing the best assistance possible to manage the daily obligations in light of the growing problems healthcare workers face. This has helped the company to expand their product line with innovative technologies
• In January, ESAOTE SPA is pleased to introduce MyLabX90, a new high-end ultrasound machine. Barco's patented dual-layer eLed display and the revitalization of the XCrystal probe family serve as the foundation for the quality components offered by MyLabX90. Compared to other product lines, these guarantee exceptional on-screen image display at high contrast resolution. This has helped the company to expand its product line

For more detailed information about the U.S. maternal health devices market report, click here –  https://www.databridgemarketresearch.com/fr/reports/us-maternal-health-devices-market